Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Auvity S, Goutal S, Caillé F, Vodovar D, Pruvost A, Wimberley C, et al. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Neuropsychopharmacology. 2021;46:1220–8.
Upadhyay J, Anderson J, Schwarz AJ, Coimbra A, Baumgartner R, Pendse G, et al. Imaging drugs with and without clinical analgesic efficacy. Neuropsychopharmacology. 2011;36:2659–73.
Tournier N, Comtat C, Lebon V, Gennisson J-L. Challenges and perspectives of the hybridization of PET with functional MRI or ultrasound for neuroimaging. Neuroscience. 2021;474:80–93.
Acknowledgements
We gratefully thank Vincent Brulon and Maud Goislard for technical assistance.
Funding
This work was performed on a platform member of France Life Imaging network (grant ANR-11-INBS-0006) and was funded by the “Lidex-PIM” project funded by the IDEX Paris-Saclay, ANR-11-IDEX-0003–02.
Author information
Authors and Affiliations
Contributions
Claire Leroy, Michel Bottlaender, and Nicolas Tournier contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Claire Leroy, Sébastien Goutal, Louise Breuil, Philippe Gervais, Hamza Cherkaoui, Philippe Ciuciu, Sylvain Auvity, Dominique Vodovar, Claude Comtat, Vincent Lebon, and Michel Bottlaender. The first draft of the manuscript was written by Claire Leroy and Nicolas Tournier and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval/clinical trial registration
This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the French Ethics Committee for Biomedical Research (Study CEA 100–040; EudraCT 2017–001897-41). Registered 02 December 2017.
Consent to participate
Signed informed consent was obtained from all individual participants included in the study.
Consent for publication
The authors affirm that human research participants provided informed consent for publication of the images.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the month.
Rights and permissions
About this article
Cite this article
Leroy, C., Goutal, S., Breuil, L. et al. A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans. Eur J Nucl Med Mol Imaging 50, 3153–3154 (2023). https://doi.org/10.1007/s00259-023-06253-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06253-w